Skip to main content

Israeli Biotech Abides Amid Bombings

When Tamir Huberman completed his degree in electrical engineering from the Hebrew University in Jerusalem in 1996, most of his fellow students were seeking work for telecom startups or dot-com firms, both exploding growth areas in Israel. Huberman instead chose to work for Medis Technologies, a small biotech company developing a lab-on-a-chip product. "Most of my friends said I was crazy, that I was missing the new economy," says Huberman, now a vice president of research at Medis. "Now most

Written bySam Jaffe
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00

When Tamir Huberman completed his degree in electrical engineering from the Hebrew University in Jerusalem in 1996, most of his fellow students were seeking work for telecom startups or dot-com firms, both exploding growth areas in Israel. Huberman instead chose to work for Medis Technologies, a small biotech company developing a lab-on-a-chip product. "Most of my friends said I was crazy, that I was missing the new economy," says Huberman, now a vice president of research at Medis. "Now most of them are out of work."

Biotechnology is indeed a growth industry in Israel. Thanks to seven world-class universities, a growing venture capital community, and a large pool of scientists and technicians--many of them immigrants from the former Soviet Union--the country is undergoing a mini-boom in biotech. In 2001 160 Israeli companies employing more than 4,000 people produced more than $800 million (US) in revenue, according to the Ministry of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays